van Dongen GAMS - Search Results

1

⁸⁹Zr-immuno-PET using the anti-LAG-3 tracer [⁸⁹Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.

Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. Miedema IHC, et al. Among authors: van dongen gams. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2068-2080. doi: 10.1007/s00259-023-06164-w. Epub 2023 Mar 2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859619 Free PMC article.

2

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

Perk LR, Visser OJ, Stigter-van Walsum M, Vosjan MJ, Visser GW, Zijlstra JM, Huijgens PC, van Dongen GA. Perk LR, et al. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45. doi: 10.1007/s00259-006-0160-0. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832633

3

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA. Perk LR, et al. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1857-67. doi: 10.1007/s00259-008-0774-5. Epub 2008 May 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18491091

4

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.

Tijink BM, Perk LR, Budde M, Stigter-van Walsum M, Visser GW, Kloet RW, Dinkelborg LM, Leemans CR, Neri D, van Dongen GA. Tijink BM, et al. Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1235-44. doi: 10.1007/s00259-009-1096-y. Epub 2009 Mar 4. Eur J Nucl Med Mol Imaging. 2009. PMID: 19259661 Free PMC article.

5

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.

Vosjan MJ, Perk LR, Roovers RC, Visser GW, Stigter-van Walsum M, van Bergen En Henegouwen PM, van Dongen GA. Vosjan MJ, et al. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):753-63. doi: 10.1007/s00259-010-1700-1. Epub 2011 Jan 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21210114 Free PMC article.

6

Synthesis of phosphine and antibody-azide probes for in vivo Staudinger ligation in a pretargeted imaging and therapy approach.

Vugts DJ, Vervoort A, Stigter-van Walsum M, Visser GW, Robillard MS, Versteegen RM, Vulders RC, Herscheid JK, van Dongen GA. Vugts DJ, et al. Bioconjug Chem. 2011 Oct 19;22(10):2072-81. doi: 10.1021/bc200298v. Epub 2011 Sep 9. Bioconjug Chem. 2011. PMID: 21854058

7

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.

Rizvi SN, Visser OJ, Vosjan MJ, van Lingen A, Hoekstra OS, Zijlstra JM, Huijgens PC, van Dongen GA, Lubberink M. Rizvi SN, et al. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):512-20. doi: 10.1007/s00259-011-2008-5. Epub 2012 Jan 5. Eur J Nucl Med Mol Imaging. 2012. PMID: 22218876 Free PMC article. Clinical Trial.

8

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.

van Dongen GA, Poot AJ, Vugts DJ. van Dongen GA, et al. Tumour Biol. 2012 Jun;33(3):607-15. doi: 10.1007/s13277-012-0316-4. Epub 2012 Jan 21. Tumour Biol. 2012. PMID: 22270450 Free PMC article. Review.

9

Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients.

Heuveling DA, de Bree R, Vugts DJ, Huisman MC, Giovannoni L, Hoekstra OS, Leemans CR, Neri D, van Dongen GA. Heuveling DA, et al. J Nucl Med. 2013 Mar;54(3):397-401. doi: 10.2967/jnumed.112.111310. Epub 2013 Jan 18. J Nucl Med. 2013. PMID: 23334725 Free article. Clinical Trial.

10

Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patients.

Heuveling DA, van Schie A, Vugts DJ, Hendrikse NH, Yaqub M, Hoekstra OS, Karagozoglu KH, Leemans CR, van Dongen GA, de Bree R. Heuveling DA, et al. J Nucl Med. 2013 Apr;54(4):585-9. doi: 10.2967/jnumed.112.115188. Epub 2013 Feb 1. J Nucl Med. 2013. PMID: 23378643 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page